
Biotech community mourns weekend loss of two celebrated figures
Mark Schoenebaum, a widely respected sell-side equity research analyst who most recently worked with Evercore ISI, and FibroGen CEO Thomas Neff, died during the weekend.
Mark Schoenebaum, a widely respected sell-side equity research analyst who most recently worked with Evercore ISI, and FibroGen CEO Thomas Neff, died during the weekend.